Syngenes Share Sale

SYNGENE international share latest news | Syngene international share analysis

Divi’s, Syngene Etc In Focus After Biosecure Act Was Kept Out Of The Key Defence Bill in The US

UBS downgrades Syngene to ‘sell’ on weak outlook, shares slip 3%

sharemarket9999

Syngene Stock Analysis: A Hidden Platform?

SOIC

Why Biocon Selling Stake in Syngene International ??💊💊

Axis Capital Upgrades Stocks Of Syngene International To Add Revises Target Price To ₹670

UBS Downgrades Syngene To Sell From Buy, Co Facing Risk Of Earnings Cuts, Says Brokerage | CNBC TV18

Stock Of the Day: Syngene | Regulatory Approvals, Earnings Visibility To Drive Upside

Syngene International Ltd: Consolidation boosts CRAMS player opportunity : Stock Of The Day

Biocon Initiates Talks for Potential Stake Sale in Biosimilar Arm & Syngene | ET Now Exclusive

Biocon Sells 5.4% Stake In Syngene To Fund Viatris Biologics Biz Acquisition | Halftime Report

Syngene Share Price | आज होगी Block Deal, निवेशित रहें या नहीं?|Biocon Share Price | Stocks In News

Market Pulse: Silver Leaf Oak Buys Into Syngene

Bloomberg TV India

Syngene International (SYNGENE) Stock Analysis: Support, Resistance, and Market Trends

Partha Kuchana - Finance

Biocon Sells Another 10% Stake In Syngene: Siddharth Mittal Speaks On The Firm's Fund Raise Pipeline

Syngene International Shares Drop The Most Since 2019 After Cutting Full Year Growth Guidance

Syngene To Buy Stelis’ Unit-3 Modal Facility | CNBC TV18

Biocon's Siddharth Mittal Speaks On Selling Stake In Syngene & Viatris Biologics Biz Acquisition

Syngene Q1 Earnings: In-Line Profits Recorded, What's The Growth Outlook Of Company In Future?

Syngene Posts Strong Q4 Earnings, Beats FY23 Revenue Growth Guidance